SAN – ParValue.app

2026
Upstart Appoints Former Santander US CEO Tim Wennes to Its Board of Directors
19 May
Santander US Survey Finds Resilient Consumers in Need of Vehicles, Used-Car Demand Persists
13 May
UK Cards and Payments Market Insights 2021-2025 and Growth Outlook 2026-2030 Featuring Lloyds Banking Group, NatWest Group, Barclays, HSBC, Santander and More
13 May
Pre-stabilisation Announcement
6 May
CH4 Natural Solutions Corporation Announces Pricing of Initial Public Offering
30 Apr
SunPower Closes $41 Million Funding Round $40 Million Debt Reduction
28 Apr
Pre-stabilisation Announcement
21 Apr
Press Release: ESCMID: Sanofi’s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
20 Apr
BNP Paribas Primary New Issues: Post-STAB Notice – No Stab NEW IMMO HOLDING
17 Apr
Madison Air Announces Pricing of Initial Public Offering
15 Apr
Americans Determined to Grow Savings with Tax Refunds, Santander Bank Survey Finds
15 Apr
Seabridge Gold Reports Maiden Snip North Resource Estimate at Its Iskut Project in B.C.’s Golden Triangle
15 Apr
Stabilization Notice – Pre-Stab – NEW IMMO HOLDING
15 Apr
Pre-stabilisation Announcement
15 Apr
Sanofi: Information concerning the total number of voting rights and shares – March 2026
14 Apr
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
13 Apr
Decision to Issue Construction Permits for Seabridge Gold’s KSM Mitchell Treaty Tunnels Delayed
10 Apr
Webster Financial Corporation Announces Q1 2026 Earnings Release
9 Apr
Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians
9 Apr
Sanofi – Combined General Meeting of April 29, 2026 – Availability of Preparatory documents
8 Apr
Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
7 Apr
Madison Air Launches Roadshow for Proposed Initial Public Offering
6 Apr
Seabridge Gold Provides Updated Mineral Resource Estimates for KSM Project
31 Mar
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
31 Mar
Press Release: AAD: new results from Sanofi’s amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
30 Mar

2026

Upstart Appoints Former Santander US CEO Tim Wennes to Its Board of Directors

Santander US Survey Finds Resilient Consumers in Need of Vehicles, Used-Car Demand Persists

UK Cards and Payments Market Insights 2021-2025 and Growth Outlook 2026-2030 Featuring Lloyds Banking Group, NatWest Group, Barclays, HSBC, Santander and More

Pre-stabilisation Announcement

CH4 Natural Solutions Corporation Announces Pricing of Initial Public Offering

SunPower Closes $41 Million Funding Round $40 Million Debt Reduction

Pre-stabilisation Announcement

Press Release: ESCMID: Sanofi’s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

BNP Paribas Primary New Issues: Post-STAB Notice – No Stab NEW IMMO HOLDING

Madison Air Announces Pricing of Initial Public Offering

Americans Determined to Grow Savings with Tax Refunds, Santander Bank Survey Finds

Seabridge Gold Reports Maiden Snip North Resource Estimate at Its Iskut Project in B.C.’s Golden Triangle

Stabilization Notice – Pre-Stab – NEW IMMO HOLDING

Pre-stabilisation Announcement

Sanofi: Information concerning the total number of voting rights and shares – March 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

Decision to Issue Construction Permits for Seabridge Gold’s KSM Mitchell Treaty Tunnels Delayed

Webster Financial Corporation Announces Q1 2026 Earnings Release

Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians

Sanofi – Combined General Meeting of April 29, 2026 – Availability of Preparatory documents

Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP

Madison Air Launches Roadshow for Proposed Initial Public Offering

Seabridge Gold Provides Updated Mineral Resource Estimates for KSM Project

Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease

Press Release: AAD: new results from Sanofi’s amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

Older